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The effects of oestrogens during pregnancy and the menstrual cycle can be seen in women and in many animals during oestrous. Such effects can often be mimicked by the administration of oestrogen. The production of oestrogen increases a thousandfold in human pregnancy (Beling 1977. Levitz & Young (977) ; marked increases also occur at oestrous in animals. However, even in pregnancy the concentrations of oestrogens are lower than those used in many, especially of the early. experiments on the biological effects of oestrogens, including those concerned with the immune systems.
In searching for a means of unifyingsome of the immunological phenomena of pregnancy, and the sex differences in morbidity and mortality due to infection (Washburn et al. (965) ,it seemedrational to speculate on the possibleeffectsof oestrogen on I Based on paper read to Section of Comparative Medicine, 16 May 1979 0141-{)768/80/030161-{)4/S01.00/0 host resistance. It is only practicable to select areas in which the broad outline of facts seem to suggest a pattern. It is alsopossibleto identify morelimited areas in which evidence seems to justify a testable hypothesis. One example of the latter type of area appears to be the peroxidatic bactericidal mechanisms of nonspecific host resistance.
In order to discuss the problem of the immunobiologyof pregnancy at least three broad categories are used. One is specificimmunity which is related to host-toleranceof foreigncompounds; the second is nonspecific immunity or nonspecific host resistance; and the third is inflammation. An apparently superficial overview is necessary since all three processes can be interrelated.
An outline of the clinical changes in host resistance during pregnancy in humans and other animals shows that alterations can occur although there is not a marked increase in infections during pregnancy. The. improvement of rheumatoid arthritis during pregnancy is widely accepted. Despite suggestions that the corticosteroids might be involved in this modulation of the inflammatory response, there is little definite evidence of such a mechanism despite extensive work to test this possibility. The clinical manifestations of syphilis are reduced in pregnancy. In contrast, systemic lupus erythematosus deteriorates in pregnancy. Crohn's disease, a chronic inflammatorydisease of unknown aetiology, is unaltered in pregnancy but does respond like rheumatoid arthritis to pharmacologicaldosesof corticosteroids(Barnes 1974). A further condition in which chronic inflammation can be involved issarcoidosis,which iscommonest in sexuallymature females. However, some aspect of hypersensitivity may be involved in this condition in view of the commonly associated erythema nodosum. Hypersensitivity can also be involved in asthma, which shows no change in pregnancy.
In man viral infections, including vaccination with liveattenuated strains, appear to be enhanced by pregnancy (Fleming 1975 , Lowrie et al, 1917 . The years of epidemic poliomyelitis in the USA provided considerable evidence of the increased susceptibility of pregnant women to this disease (Priddle et al. 1952 , Rindge 1957 .
In experimental animals mice normallyresistant to foot and mouth disease become susceptible in pregnancy, and in mice the susceptibility to coxsackie viruses increases with gestational age (Lowrie et al. 1977) . The available evidence therefore suggeststhat virus infectionscan produce marked effects at times of raised oestrogen production.
The effects of bacterial infection in pregnancy can be enhanced. Acute pyelonephritis is more common in pregnancy than at other times, affecting about 4% of pregnant women. However, bacteriuria is probably not increased. Oestrogen administration can increase the development of pyelonephritis in experimental animals; in one study this was apparent for Staph. aureus but not E. coli, This difference may be explained by another study in which an increase in effects was only observed with E. coli strains isolated from urinary tract infections, not from gastrointestinal infections (Lowrie et al. 1977) . Local factors, such as dilatation of the ureters and increased concentrations of bacterial nutrients in the urine, have been commonly linked to the increased incidence of pyelonephritis in pregnancy. However, Mitchell et al. 1970 showed that there was an impairment of the bactericidal activity of bacteriuric pregnant women's phagocytes in relation to those from other pregnant women. Before effective chemotherapy was available, bacterial pneumonia was associated with an increased mortality compared to the disease in the non-pregnant (Lowrie et al. 1977) . Pneumococcal meningitis was found to be more common and of greater severity in pregnancy in Nigeria (Lucas 1964) . Possibly the most clinically important decrease in host resistance during pregnancy is that to malaria; this was clearly demonstrated in a prospective Nigerian study in which prophylactic chemotherapy effectively abolished the associated haemolytic anaemia (Gilles et al. 1969) .
Resistance to infection involves a wide variety of nonspecific mechanisms, including the inflammatory reaction and nonspecific bactericidal secretions. The balance between such factors and a commensal microflora are most readily inspected in the human mouth. Extensive studies in the USA, India and Wales have shown that gingivitis increases markedly in pregnancy and that this change is reversed after delivery (Cohen et al. 1969) . The value of these observations would appear to be that the skilled periodontologist can perform serial noninvasive observations of the balance between host resistance and the oral microflora.
In the area of specific immunity one of the central questions is why the mother does not reject the fetus as she does any othergenetically dissimilar graft. The mechanisms which may be involved have been reviewed (Edwards & Coombs 1975 , Edwards et al. 1975 , Rocklin et al. 1979 ). Factors which have been suggested are that the mechanical properties of the trophoblast constitute a barrier. This barrier is incomplete, however, because cells and antigens can be shown to cross it. The suggestion that the trophoblast is antigenically neutral is based on evidence in which transplantation antigens were not detected; sensitive methods have shown small quantities to bepresent. It is also true that some fetal and/or placental proteins which differ from those in the adult (for example alphafetoprotein as a major circulating plasma protein and placental alkaline phosphatase) may reappear in tumour cells in adults and can induce antibodies even though these fetal proteins were part of every adult's 'experience'. Some evidence suggests that the pregnant uterus with a decidual reaction is less immunologically 'reactive', However, the pregnant uterus is capable of rejecting grafts and the placenta can implant successfully outside the uterus. Systemic alterations are suggested by evidence of a decrease in the size of the thymus during pregnancy. At least part of this decrease is probably due to alterations in sex hormone concentrations (see Castro 1978 , Rocklin et al. 1979 .
In this incomplete outline of the problem it would appear that qualitative assessment does not allow any solution. It remains possible that a quantitative treatment of precisely defined processes might be enlightening, Despite our lack of understanding, it seems that a depression of specific immunity must occur during pregnancy.
In the female the metabolic changes associated with pregnancy and reproduction appear to have widespread effects on host tolerance of the fetus and on a variety of diseases in which we imagine host resistance to be involved. The survival of the fetus and the decreased resistance to some virus 'infections' are clear. Other changes seem complex and sometimes contradictory. It is possible that an increased understanding of the mechanisms involved may help to resolve some of the apparent contradictions.
One suggestion which may be consistent with much of the above evidence is that acute inflammation may be stimulated and chronic inflammation inhibited by pregnancy. These effects could be, in part, mediated by oestrogens. An examination of the effects of pregnancy on some of the mediators of inflammation suggests that this remains a possibility.
There is evidence for a stimulatory effect of oestrogens on the phagocytic microbicidal polymorphonuclear neutrophil leukocyte (PMNL). The numbers and the activity of PMNL are increased in pregnancy (Mitchell et al. 1970 , Hytten & Lind 1973 , Plum et al. 1978 . There is an increase in the numbers of PMNL at the middle of the menstrual cycle (Bain & England 1975) . The induction of oestrogen production by exogenous gonadotrophins is significantly correlated with increased numbers of neutrophils (Cruikshank el al. 1972) . There is also an increase at the middle of the menstrual cycle in specific activities of some enzymes, especially the microbicidal myeloperoxidase (MPO) (Cockle & Harkness 1978) in leukocyte preparations which consist largely of neutrophils. Oestrogens stimulate granulopoiesis in mice (Fox 1961) and in tissue culture (Reisner 1966) , although relatively large doses of oestrogen were used in these two sets of investigations. The importance of these cells in host resistance is shown by the serious infections due to agranulocytosis and to a lesser extent neutropenia. The 'polymorph leukocytosis' of many bacterial infections suggests that increased numbers of PMNL are important in host resistance.
The well documented increase in neutrophil numbers and activity could be consistent with the suggestion that the acute phase of inflammation may be increased under oestrogenic stimulation. It is also consistent with the increase in complement in serum during pregnancy (Kitzmiller et al. 1973) since components of the complement cascade increase neutrophil activity amongst their other actions. Other well defined increases in proteins during pregnancy may be consistent with some suppression of chronic inflammation. There is increasing evidence for a modifying role for alpha-I-antitrypsin in cellular damage (Carrell & Owen 1979) .This protein reduces protease activity which is believed to cause at least some tissue damage and which can arise from neutrophils. Alpha-lantitrypsin increases about twofold during pregnancy (Faarvang & Lauriston 1963 , Ganrot & Bjerre 1967 , Studd 1975 and by treatment with oestrogens (Laurell et al, 1967) . Less marked increases in another protease inhibitor, alpha-Zmacroglobulin, also occur in pregnancy and during oestrogenic stimulation.
There appears to be some stimulation of reticuloendothelial system phagocytic activity in man (Magarey & Baum 1971) and in experimental animals (Nicol et al. 1964 ,NicoletaI.1966 , Wexler & Kantor 1966 . This stimulation of macrophage function has been suggested as a part of the beneficial effects of hormones on tumours (Castro 1978) . There is also a significant rise in monocytes in peripheral blood during human pregnancy; these cells confusingly carry some of the same surface markers as lymphocytes (Plum et al. 1978) .
There appear to be changes in other nonspecific potentially ba~te.ri ci .dal~eroxidati~m~chan~sms. Peroxidase activity In milk and sahva IS beheved to be involved in host resistance. Peroxidase activity in human newborn saliva as well as colostrum and milk falls in the neonatal period (Gothefors & Marklund 1975) ,which is consistent with falls in oestrogen concentrations in this period. In addition, peroxidase activity in guineapig milk is increased in parallel with oestrogen production at oestrus and this increase is similar to increased bactericidal activities (Stephens et al, 1979) . This animal may be especially suitable for such studies because of the high peroxidase activity in its milk; this may render other nonspecific antimicrobial factors, which include lysozyme and lactoferrin (Reiter 1978) , less important. Altera-tions in lactoperoxidase thus change overall microbicidal acti vity. This isconsistent with evidence from the absence of myeloperoxidase in the PMNL. This inborn error is associated with a marked defect in microbicidal activity (Lehrer & Cline 1969 , Klebanoff 1971 , Bellante & Dayton 1975 . However, the infections associated with MPO deficiency are mild especially when compared with the often fatal infections caused by agranulocytosis. This may be due to alternative microbicidal mechanisms which are demonstrable in the PMNL. Such mechanisms may be automatically activated by increases in substrate concentrations arising from defects in the main pathway (Harkness 1977) .
This apparent diversion is perhaps justified because it provides a little of the evidence for reserve capacity, safety margins" or apparent redundancy in biological systems. One form of reserve capacity is the existence of parallel apparently self-compensating pathways. It is clear from the large amount of evidence available from inherited metabolic disease that there are quantitatively large safety factors in the activities of the individual enzymes. The biological effects of enzyme deficiencies are generally only apparent when in vitro activities are 1-10% or less of the mean control activity."" No clinical disease is apparent in the large numbers ofheterozygotes for many severe defects despite the relevant enzyme activities being only half mean control activities.
If such redundancy is general then the interpretation of-much available evidence is made more difficult. This seems possible despite the needs for economy of weight and of space in any selfpropelling mobile system. Only those experiments which make quantitatively large changes and in which parallel pathways are blocked may show effects. It is possible that a critical review of changes of host resistance may conclude that there is little evidence of changes of host resistance in pregnancy because studies do not always show definite results. However, some indication of real change may be obtained if all good studies in a limited area show consistent changes.
To Rocklin and his colleagues (1979), reviewing the problem of the immunobiology of pregnancy, a subtle shift in balance seemed to occur in pregnancy; these authors and others have recognized the possibility that such changes may be due to sex hormones. Since widespread metabolic regulation probably occurs in alterations in specific immunity, the controls for such change may be in part hormonal. The oestrogens seem likely to be a part of such controls. The direct and indirect modulation of primary hormonal effects by other hormones is widely accepted in endocrinology. Tentatively it therefore seems justifiable to repeat the suggestion that oestrogens may depress certain aspects of specific immunity; this is consistent with the increased susceptibility to some virus infections in pregnancy. The evidence that oestrogens can increase some parts of the mechanisms responsible for nonspecific host resistance, the PMNL and peroxidase, seem to rest on a more definite set of clinical and experimental findings.
It seems possible that a decrease in one component of host resistance, for example certain aspects of specific immunity, is balanced by an increase in other components, the neutrophils, to maintain an overal1balance. Such a balance would be necessary for survival. Tolerance of the fetal graft is certainly not linked to epidemiological evidence of a marked increase in infections during pregnancy. Therefore the changes in overal1 host resistance are subtle and necessarily of limited clinical importance. It may be only by simplifications of the type inherent in the selection of oestrogen effects that it will be practicable to outline a tentative hypothesis. It is possible that there may not be one answer, but several, to the problems of the immunobiology of pregnancy.
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